Targets and indicators
Target 3.1
By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births
Indicator 3.1.1
Target 3.2
By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‐5 mortality to at least as low as 25 per 1,000 live births
Target 3.3
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
Indicator 3.3.1
Target 3.4
By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being
Indicator 3.4.1
Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
Target 3.5
Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
Indicator 3.5.1
Indicator 3.5.2
Target 3.6
By 2020, halve the number of global deaths and injuries from road traffic accidents
Target 3.7
By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes
Indicator 3.7.1
Indicator 3.7.2
Target 3.8
Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
Indicator 3.8.2
Target 3.9
By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination
Target 3.a
Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate
Indicator 3.a.1
Target 3.b
Support the research and development of vaccines and medicines for the communicable and non‐communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
Indicator 3.b.1
Indicator 3.b.2
Indicator 3.b.3
Target 3.c
Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States
Target 3.d
Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks